Literature DB >> 2758217

Effect of aminophylline on cisplatin nephrotoxicity in the rat.

H T Heidemann1, S Müller, L Mertins, G Stepan, K Hoffmann, E E Ohnhaus.   

Abstract

1. The effect of the methylxanthine aminophylline on cisplatin (5 mg kg-1 i.v.)-induced acute renal failure was investigated in the rat. Renal function was measured 5 days after cisplatin administration. 2. Cisplatin caused a polyuric acute renal failure. The creatinine clearance was significantly reduced. 3. Aminophylline (24 mg kg-1 12h-1) ameliorated the cisplatin nephrotoxicity when administered during the maintenance phase of acute tubular necrosis. However, it had no effect when only administered prophylactically before the cisplatin application. 4. Enprofylline (20 mg kg-1 4h-1 with dose adjustment), a methylxanthine lacking adenosine receptor antagonism in comparison to aminophylline, had no protective effect on cisplatin nephrotoxicity. 5. Adenosine is a renal vasoconstrictor and decreases glomerular filtration rate. Endogenous adenosine in the kidney is formed by degradation of ATP and is thought to be involved in various forms of acute renal failure. The results suggest that adenosine may be involved in the haemodynamic changes in the kidney induced by cisplatin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2758217      PMCID: PMC1854525          DOI: 10.1111/j.1476-5381.1989.tb11956.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Renal effects of adenosine and their inhibition by theophylline in dogs.

Authors:  H Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

Review 2.  RENAL HEMODYNAMICS.

Authors:  K THURAU
Journal:  Am J Med       Date:  1964-05       Impact factor: 4.965

3.  Tissue content of adenosine, inosine and hypoxanthine in the rat kidney after ischemia and postischemic recirculation.

Authors:  H Osswald; H J Schmitz; R Kemper
Journal:  Pflugers Arch       Date:  1977-10-19       Impact factor: 3.657

4.  Adenosine production in the ischemic kidney.

Authors:  W L Miller; R A Thomas; R M Berne; R Rubio
Journal:  Circ Res       Date:  1978-09       Impact factor: 17.367

5.  Mechanism of adenosine-mediated decreases in glomerular filtration rate in dogs.

Authors:  H Osswald; W S Spielman; F G Knox
Journal:  Circ Res       Date:  1978-09       Impact factor: 17.367

6.  Adenosine as a possible mediator of metabolic control of glomerular filtration rate.

Authors:  H Osswald; G Nabakowski; H Hermes
Journal:  Int J Biochem       Date:  1980

7.  Cis-diamminedichlorplatinum-induced acute renal failure in the rat.

Authors:  S Chopra; J S Kaufman; T W Jones; W K Hong; M K Gehr; R J Hamburger; W Flamenbaum; B F Trump
Journal:  Kidney Int       Date:  1982-01       Impact factor: 10.612

8.  Cisplatin nephrotoxicity in rats: defect in papillary hypertonicity.

Authors:  R Safirstein; P Miller; S Dikman; N Lyman; C Shapiro
Journal:  Am J Physiol       Date:  1981-08

9.  Differentiation between bronchodilation and universal adenosine antagonism among xanthine derivatives.

Authors:  C G Persson; J A Karlsson; I Erjefält
Journal:  Life Sci       Date:  1982-06-21       Impact factor: 5.037

10.  Hypothesis: adenosine mediates hemodynamic changes in renal failure.

Authors:  P C Churchill; A K Bidani
Journal:  Med Hypotheses       Date:  1982-03       Impact factor: 1.538

View more
  13 in total

1.  Antifungal activity of HWA-138 and amphotericin B in experimental systemic candidiasis.

Authors:  K M Wasan; K Vadiei; D R Luke; A Keyhani; R A White; T J McQueen; R Mehta; G Lopez-Berestein
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

Review 2.  Purinergic signalling in the kidney in health and disease.

Authors:  Geoffrey Burnstock; Louise C Evans; Matthew A Bailey
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

Review 3.  Adenosine receptors and the kidney.

Authors:  Volker Vallon; Hartmut Osswald
Journal:  Handb Exp Pharmacol       Date:  2009

4.  Renal clearance of a recombinant granulocyte colony-stimulating factor, nartograstim, in rats.

Authors:  T Kuwabara; Y Ishikawa; H Kobayashi; S Kobayashi; Y Sugiyama
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

5.  Human adipose-derived mesenchymal stem cells repair cisplatin-induced acute kidney injury through antiapoptotic pathways.

Authors:  Weiqi Yao; Qinyong Hu; Yuhong Ma; Wenping Xiong; Tingting Wu; Jun Cao; Dongcheng Wu
Journal:  Exp Ther Med       Date:  2015-05-21       Impact factor: 2.447

Review 6.  Methylxanthines and the kidney.

Authors:  Hartmut Osswald; Jürgen Schnermann
Journal:  Handb Exp Pharmacol       Date:  2011

7.  Protection against acute kidney injury via A(1) adenosine receptor-mediated Akt activation reduces liver injury after liver ischemia and reperfusion in mice.

Authors:  Sang Won Park; Sean W C Chen; Mihwa Kim; Kevin M Brown; Vivette D D'Agati; H Thomas Lee
Journal:  J Pharmacol Exp Ther       Date:  2010-03-22       Impact factor: 4.030

8.  Benefit of theophylline administration in tacrolimus-induced nephrotoxicity in rats.

Authors:  Gwenn E McLaughlin; Michelle Schober; Maria Perez; Phillip Ruiz; Bernard W Steele; Carolyn Abitbol
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

9.  Effects of a selective adenosine A1 receptor antagonist on the development of cyclosporin nephrotoxicity.

Authors:  V S Balakrishnan; C J von Ruhland; D F Griffiths; G A Coles; J D Williams
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 10.  WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.

Authors:  M Treskes; W J van der Vijgh
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.